"10.1371_journal.pmed.0050239","plos medicine","2008-12-09T00:00:00Z","Charlie W Lees; William J Zacharias; Mark Tremelling; Colin L Noble; Elaine R Nimmo; Albert Tenesa; Jennine Cornelius; Leif Torkvist; John Kao; Susan Farrington; Hazel E Drummond; Gwo-Tzer Ho; Ian D R Arnott; Henry D Appelman; Lauri Diehl; Harry Campbell; Malcolm G Dunlop; Miles Parkes; Sarah E M Howie; Deborah L Gumucio; Jack Satsangi","Gastrointestinal Unit, Molecular Medicine Centre, University of Edinburgh, Edinburgh, United Kingdom; Immunobiology Group, Medical Research Council (MRC) Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America; Inflammatory Bowel Disease (IBD) Research Group, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom; Colon Cancer Genetics Group, MRC Human Genetics Unit, Western General Hospital, Edinburgh, United Kingdom; Department of Pathology, Genentech, Inc, South San Francisco, California, United States of America; Department of Medical & Surgical Gastroenterology, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America","Â¶ These authors are joint senior authors on this work.","Lauri Diehl is a paid employee of Genentech, Inc and a stockholder in that company. While this paper does not describe any Genentech product, it is possible that these findings may be relevant to a pathway or pathways of interest to the company for current or future therapeutic agents. None of the other authors have any competing interests to declare.","2008","12","Charlie W Lees","CWL",21,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
